December 1, 2017 Dr. Teri Chou promoted from Chief Scientific Officer to CEO

Edmonds, Washington – December 1, 2017   Following earning Modus Health’s first pharmaceutical contract, Dr. Teri Chou has been promoted from Chief Scientific Officer to CEO. Dr. Chou was a founding employee of Modus Health in 2013 as Director of Clinical Research. She stayed during the restructure of 2016 as the remaining employee. During this time, she earned an NIH grant with Harvard Medical School that provided funds for creating the StepWatch 4 prototype. This prototype was used to earn the first pharmaceutical contract with Pfizer and investment funding for product development and company growth.